{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:59:35Z","timestamp":1780491575522,"version":"3.54.1"},"reference-count":34,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1248\/bpb.b15-00109","type":"journal-article","created":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T22:06:47Z","timestamp":1430431607000},"page":"774-780","source":"Crossref","is-referenced-by-count":8,"title":["Gene Ablation of Carnitine\/Organic Cation Transporter 1 Reduces Gastrointestinal Absorption of 5-Aminosalicylate in Mice"],"prefix":"10.1248","volume":"38","author":[{"given":"Takuya","family":"Shimizu","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Kijima","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Masuo","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ishimoto","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritaka","family":"Nakamichi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Kato","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) The National Institute for Health and Care Excellence (NICE) clinical guideline 166. \u201cUlcerative colitis: Management in adults, children and young people.\u201d: \u2039https:\/\/www.nice.org.uk\/guidance\/cg166\u203a, published in June 2013."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kornbluth A, Sachar DB, Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. <i>Am. J. Gastroenterol.<\/i>, <b>105<\/b>, 501\u2013523, quiz, 524 (2010).","DOI":"10.1038\/ajg.2009.727"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. <i>Clin. Gastroenterol. Hepatol.<\/i>, <b>10<\/b>, 639\u2013645 (2012).","DOI":"10.1016\/j.cgh.2012.01.010"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Baan B, Dihal AA, Hoff E, Bos CL, Voorneveld PW, Koelink PJ, Wildenberg ME, Muncan V, Heijmans J, Verspaget HW, Richel DJ, Hardwick JC, Hommes DW, Peppelenbosch MP, van den Brink GR. 5-Aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer. <i>Gut<\/i>, <b>61<\/b>, 1708\u20131715 (2012).","DOI":"10.1136\/gutjnl-2011-301626"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Munding J, Ziebarth W, Pox CP, Ladigan S, Reiser M, H\u00fcppe D, Brand L, Schmiegel W, Tannapfel A, Reinacher-Schick AC. The influence of 5-aminosalicylic acid on the progression of colorectal adenomas <i>via<\/i> the \u03b2-catenin signaling pathway. <i>Carcinogenesis<\/i>, <b>33<\/b>, 637\u2013643 (2012).","DOI":"10.1093\/carcin\/bgr306"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Rousseaux C, El-Jamal N, Fumery M, Dubuquoy C, Romano O, Chatelain D, Langlois A, Bertin B, Buob D, Colombel JF, Cortot A, Desreumaux P, Dubuquoy L. The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPAR\u03b3. <i>Carcinogenesis<\/i>, <b>34<\/b>, 2580\u20132586 (2013).","DOI":"10.1093\/carcin\/bgt245"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Reinacher-Schick A, Schoeneck A, Graeven U, Schwarte-Waldhoff I, Schmiegel W. Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells. <i>Carcinogenesis<\/i>, <b>24<\/b>, 443\u2013451 (2003).","DOI":"10.1093\/carcin\/24.3.443"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Zhao LN, Li JY, Yu T, Chen GC, Yuan YH, Chen QK. 5-Aminosalicylates reduce the risk of colorectal neoplasia in patients with ulcerative colitis: an updated meta-analysis. <i>PLoS ONE<\/i>, <b>9<\/b>, e94208 (2014).","DOI":"10.1371\/journal.pone.0094208"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Greenfield SM, Boswell DJ, Punchard NA, Thompson RP. The effects of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid on lipid peroxidation in erythrocytes and prostaglandin production by mononuclear cells. <i>Aliment. Pharmacol. Ther.<\/i>, <b>6<\/b>, 671\u2013683 (1992).","DOI":"10.1111\/j.1365-2036.1992.tb00731.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hawkey CJ, Lo Casto M. Inhibition of prostaglandin synthetase in human rectal mucosa. <i>Gut<\/i>, <b>24<\/b>, 213\u2013217 (1983).","DOI":"10.1136\/gut.24.3.213"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Yu DK, Elvin AT, Morrill B, Eichmeier LS, Lanman RC, Lanman MB, Giesing DH. Effect of food coadministration on 5-aminosalicylic acid oral suspension bioavailability. <i>Clin. Pharmacol. Ther.<\/i>, <b>48<\/b>, 26\u201333 (1990).","DOI":"10.1038\/clpt.1990.113"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) K\u00f6nig J, Glaeser H, Keiser M, Mandery K, Klotz U, Fromm MF. Role of organic anion-transporting polypeptides for cellular mesalazine (5-aminosalicylic acid) uptake. <i>Drug Metab. Dispos.<\/i>, <b>39<\/b>, 1097\u20131102 (2011).","DOI":"10.1124\/dmd.110.034991"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, Tsuji A. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. <i>FEBS Lett.<\/i>, <b>419<\/b>, 107\u2013111 (1997).","DOI":"10.1016\/S0014-5793(97)01441-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Yabuuchi H, Tamai I, Nezu J, Sakamoto K, Oku A, Shimane M, Sai Y, Tsuji A. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>289<\/b>, 768\u2013773 (1999).","DOI":"10.1016\/S0022-3565(24)38199-6"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kawasaki Y, Kato Y, Sai Y, Tsuji A. Functional characterization of human organic cation transporter OCTN1 single nucleotide polymorphisms in the Japanese population. <i>J. Pharm. Sci.<\/i>, <b>93<\/b>, 2920\u20132926 (2004).","DOI":"10.1002\/jps.20190"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Gr\u00fcndemann D, Harlfinger S, Golz S, Geerts A, Lazar A, Berkels R, Jung N, Rubbert A, Sch\u00f6mig E. Discovery of the ergothioneine transporter. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>102<\/b>, 5256\u20135261 (2005).","DOI":"10.1073\/pnas.0408624102"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nakamura T, Nakanishi T, Haruta T, Shirasaka Y, Keogh JP, Tamai I. Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation\/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption. <i>Mol. Pharm.<\/i>, <b>7<\/b>, 187\u2013195 (2010).","DOI":"10.1021\/mp900206j"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Jong NN, Nakanishi T, Liu JJ, Tamai I, McKeage MJ. Oxaliplatin transport mediated by organic cation\/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>338<\/b>, 537\u2013547 (2011).","DOI":"10.1124\/jpet.111.181297"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Pochini L, Scalise M, Galluccio M, Indiveri C. Regulation by physiological cations of acetylcholine transport mediated by human OCTN1 (SLC22A4). Implications in the non-neuronal cholinergic system. <i>Life Sci.<\/i>, <b>91<\/b>, 1013\u20131016 (2012).","DOI":"10.1016\/j.lfs.2012.04.027"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Urban TJ, Brown C, Castro RA, Shah N, Mercer R, Huang Y, Brett CM, Burchard EG, Giacomini KM. Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin. <i>Clin. Pharmacol. Ther.<\/i>, <b>83<\/b>, 416\u2013421 (2008).","DOI":"10.1038\/sj.clpt.6100271"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kato Y, Kubo Y, Iwata D, Kato S, Sudo T, Sugiura T, Kagaya T, Wakayama T, Hirayama A, Sugimoto M, Sugihara K, Kaneko S, Soga T, Asano M, Tomita M, Matsui T, Wada M, Tsuji A. Gene knockout and metabolome analysis of carnitine\/organic cation transporter OCTN1. <i>Pharm. Res.<\/i>, <b>27<\/b>, 832\u2013840 (2010).","DOI":"10.1007\/s11095-010-0076-z"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sugiura T, Kato S, Shimizu T, Wakayama T, Nakamichi N, Kubo Y, Iwata D, Suzuki K, Soga T, Asano M, Iseki S, Tamai I, Tsuji A, Kato Y. Functional expression of carnitine\/organic cation transporter OCTN1\/SLC22A4 in mouse small intestine and liver. <i>Drug Metab. Dispos.<\/i>, <b>38<\/b>, 1665\u20131672 (2010).","DOI":"10.1124\/dmd.110.032763"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Nakamichi N, Shima H, Asano S, Ishimoto T, Sugiura T, Matsubara K, Kusuhara H, Sugiyama Y, Sai Y, Miyamoto K, Tsuji A, Kato Y. Involvement of carnitine\/organic cation transporter OCTN1\/SLC22A4 in gastrointestinal absorption of metformin. <i>J. Pharm. Sci.<\/i>, <b>102<\/b>, 3407\u20133417 (2013).","DOI":"10.1002\/jps.23595"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Taubert D, Jung N, Goeser T, Schomig E. Increased ergothioneine tissue concentrations in carriers of the Crohn\u2019s disease risk-associated 503F variant of the organic cation transporter OCTN1. <i>Gut<\/i>, <b>58<\/b>, 312\u2013314 (2009).","DOI":"10.1136\/gut.2008.164418"},{"key":"25","unstructured":"25) Shimizu T, Masuo Y, Takahashi S, Nakamichi N, Kato Y. Organic cation transporter Octn1-mediated uptake of food-derived antioxidant ergothioneine into infiltrating macrophages during intestinal inflammation in mice. <i>Drug Metab. Pharmacokinet.<\/i>, in press."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Caliendo G, Santagada V, Perissutti E, Severino B, Fiorino F, Warner TD, Wallace JL, Ifa DR, Antunes E, Cirino G, de Nucci G. Synthesis of substituted benzamides as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 but do not cause gastric damage. <i>Eur. J. Med. Chem.<\/i>, <b>36<\/b>, 517\u2013530 (2001).","DOI":"10.1016\/S0223-5234(01)01251-X"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Nishimura T, Amano N, Kubo Y, Ono M, Kato Y, Fujita H, Kimura Y, Tsuji A. Asymmetric intestinal first-pass metabolism causes minimal oral bioavailability of midazolam in cynomolgus monkey. <i>Drug Metab. Dispos.<\/i>, <b>35<\/b>, 1275\u20131284 (2007).","DOI":"10.1124\/dmd.106.013037"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Hussain FN, Ajjan RA, Moustafa M, Anderson JC, Riley SA. Simple method for the determination of 5-aminosalicylic and <i>N<\/i>-acetyl-5-aminosalicylic acid in rectal tissue biopsies. <i>J. Chromatogr. B: Biomed. Sci. Appl.<\/i>, <b>716<\/b>, 257\u2013266 (1998).","DOI":"10.1016\/S0378-4347(98)00323-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Zhou SY, Fleisher D, Pao LH, Li C, Winward B, Zimmermann EM. Intestinal metabolism and transport of 5-aminosalicylate. <i>Drug Metab. Dispos.<\/i>, <b>27<\/b>, 479\u2013485 (1999).","DOI":"10.1016\/S0090-9556(24)15210-5"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Davies B, Morris T. Physiological parameters in laboratory animals and humans. <i>Pharm. Res.<\/i>, <b>10<\/b>, 1093\u20131095 (1993).","DOI":"10.1023\/A:1018943613122"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Imanaga J, Kotegawa T, Imai H, Tsutsumi K, Yoshizato T, Ohyama T, Shirasaka Y, Tamai I, Tateishi T, Ohashi K. The effects of the SLCO2B1 c.1457C&gt;T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans. <i>Pharmacogenet. Genomics<\/i>, <b>21<\/b>, 84\u201393 (2011).","DOI":"10.1097\/FPC.0b013e32834300cc"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Ieiri I, Doi Y, Maeda K, Sasaki T, Kimura M, Hirota T, Chiyoda T, Miyagawa M, Irie S, Iwasaki K, Sugiyama Y. Microdosing clinical study: pharmacokinetic, pharmacogenomic (SLCO2B1), and interaction (grapefruit juice) profiles of celiprolol following the oral microdose and therapeutic dose. <i>J. Clin. Pharmacol.<\/i>, <b>52<\/b>, 1078\u20131089 (2012).","DOI":"10.1177\/0091270011408612"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Benet LZ, Broccatelli F, Oprea TI. BDDCS applied to over 900 drugs. <i>AAPS J.<\/i>, <b>13<\/b>, 519\u2013547 (2011).","DOI":"10.1208\/s12248-011-9290-9"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Shugarts S, Benet LZ. The role of transporters in the pharmacokinetics of orally administered drugs. <i>Pharm. Res.<\/i>, <b>26<\/b>, 2039\u20132054 (2009).","DOI":"10.1007\/s11095-009-9924-0"}],"container-title":["Biological &amp; Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/38\/5\/38_b15-00109\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T19:06:49Z","timestamp":1748372809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/38\/5\/38_b15-00109\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b15-00109","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}